Alpha Cognition (NASDAQ:ACOG - Get Free Report) posted its quarterly earnings results on Monday. The company reported ($0.51) earnings per share for the quarter, missing the consensus estimate of ($0.48) by ($0.03), Zacks reports.
Alpha Cognition Price Performance
ACOG stock traded up $0.23 during trading on Wednesday, hitting $5.08. 28,595 shares of the company's stock traded hands, compared to its average volume of 77,693. The company has a market capitalization of $81.38 million, a price-to-earnings ratio of -1.98 and a beta of 2.50. Alpha Cognition has a 1 year low of $4.66 and a 1 year high of $7.00. The stock's fifty day moving average price is $5.79.
Wall Street Analyst Weigh In
A number of equities research analysts have weighed in on ACOG shares. Raymond James raised Alpha Cognition to a "moderate buy" rating in a research report on Tuesday, March 25th. HC Wainwright restated a "buy" rating and set a $20.00 price target on shares of Alpha Cognition in a research note on Monday.
Check Out Our Latest Research Report on ACOG
About Alpha Cognition
(
Get Free Report)
Alpha Cognition, Inc is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Further Reading
Before you consider Alpha Cognition, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alpha Cognition wasn't on the list.
While Alpha Cognition currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
